Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference
June 15, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, June 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that Harry Stylli, PhD, CEO, chairman of the board, and co-founder...
Progenity Announces $40 Million Private Placement
June 10, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive securities...
Progenity Announces Poster Presentations at Digestive Disease Week 2021
May 24, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted...
Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
May 12, 2021 07:29 ET
|
Progenity, Inc.
SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced preliminary results, subject to final audited study reports by its...
Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
May 11, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
NOTICE TO DISREGARD -- CDx Diagnostics
May 04, 2021 11:13 ET
|
CDx Diagnostics
SUFFERN, N.Y., May 04, 2021 (GLOBE NEWSWIRE) -- We are advised by CDx Diagnostics that journalists and other readers should disregard the news release, “CDx Diagnostics Contracts with Wellmark Blue...
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
April 26, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Capital Digestive Care Announces Transaction with Gastrointestinal & Liver Specialists of Tidewater, PLLC
April 13, 2021 11:39 ET
|
Capital Digestive Care
Silver Spring, MD, April 13, 2021 (GLOBE NEWSWIRE) -- Capital Digestive Care, the largest private gastroenterology practice in the Mid-Atlantic Region, announced a transaction with Gastrointestinal...
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
April 06, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Capital Digestive Care Partners with Temple Hills Gastroenterology, Expanding Gastroenterology Services in Prince George’s County, Maryland
March 22, 2021 06:02 ET
|
Capital Digestive Care
Silver Spring, MD, March 22, 2021 (GLOBE NEWSWIRE) -- Capital Digestive Care, the largest private gastroenterology practice in the Mid-Atlantic, is pleased to announce a new partnership with...